[Problems of interaction between 5,5 1 -diphenylhydantoin (Hydantoinal) and other drugs].
D000305:Adrenal Cortex Hormones / Q000494:pharmacology; D000925:Anticoagulants / Q000494:pharmacology; D000995:Antitubercular Agents; D001463:Barbiturates / Q000494:pharmacology; D001711:Biotransformation; D004347:Drug Interactions; D004357:Drug Synergism; D004790:Enzyme Induction; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology; D007030:Hypothalamo-Hypophyseal System / Q000187:drug effects; D008099:Liver / Q000201:enzymology; D010672:Phenytoin / Q000494:pharmacology*; D010913:Pituitary-Adrenal System / Q000187:drug effects
D000305:Adrenal Cortex Hormones; D000925:Anticoagulants; D000995:Antitubercular Agents; D001463:Barbiturates; D007004:Hypoglycemic Agents; D010672:Phenytoin
Niektóre problemy interakcji 5,5 1 -dwufenylohydantoiny (Hydantoinal) z innymi lekami.